2164 related articles for article (PubMed ID: 23290630)
1. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.
Titulaer MJ; McCracken L; Gabilondo I; Armangué T; Glaser C; Iizuka T; Honig LS; Benseler SM; Kawachi I; Martinez-Hernandez E; Aguilar E; Gresa-Arribas N; Ryan-Florance N; Torrents A; Saiz A; Rosenfeld MR; Balice-Gordon R; Graus F; Dalmau J
Lancet Neurol; 2013 Feb; 12(2):157-65. PubMed ID: 23290630
[TBL] [Abstract][Full Text] [Related]
2. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.
Gresa-Arribas N; Titulaer MJ; Torrents A; Aguilar E; McCracken L; Leypoldt F; Gleichman AJ; Balice-Gordon R; Rosenfeld MR; Lynch D; Graus F; Dalmau J
Lancet Neurol; 2014 Feb; 13(2):167-77. PubMed ID: 24360484
[TBL] [Abstract][Full Text] [Related]
3. Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
de Montmollin E; Demeret S; Brulé N; Conrad M; Dailler F; Lerolle N; Navellou JC; Schwebel C; Alves M; Cour M; Engrand N; Tonnelier JM; Maury E; Ruckly S; Picard G; Rogemond V; Magalhaes É; Sharshar T; Timsit JF; Honnorat J; Sonneville R;
Am J Respir Crit Care Med; 2017 Feb; 195(4):491-499. PubMed ID: 27552490
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for anti-NMDA receptor encephalitis: Experience from a single center in Taiwan.
Kong SS; Chen YJ; Su IC; Lin JJ; Chou IJ; Chou ML; Hung PC; Hsieh MY; Wang YS; Chou CC; Wang HS; Lin KL;
Pediatr Neonatol; 2019 Aug; 60(4):417-422. PubMed ID: 30449706
[TBL] [Abstract][Full Text] [Related]
5. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis.
Armangue T; Spatola M; Vlagea A; Mattozzi S; Cárceles-Cordon M; Martinez-Heras E; Llufriu S; Muchart J; Erro ME; Abraira L; Moris G; Monros-Giménez L; Corral-Corral Í; Montejo C; Toledo M; Bataller L; Secondi G; Ariño H; Martínez-Hernández E; Juan M; Marcos MA; Alsina L; Saiz A; Rosenfeld MR; Graus F; Dalmau J;
Lancet Neurol; 2018 Sep; 17(9):760-772. PubMed ID: 30049614
[TBL] [Abstract][Full Text] [Related]
6. [Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].
Wang GL; Yin F; Wang Y; Zhang WX; He F; Yang LF; Wu LW; Peng J
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):125-130. PubMed ID: 30695887
[No Abstract] [Full Text] [Related]
7. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
[TBL] [Abstract][Full Text] [Related]
9. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
[TBL] [Abstract][Full Text] [Related]
10. Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis: A Cohort Study in Western China.
Gong X; Chen C; Liu X; Lin J; Li A; Guo K; Zhou D; Hong Z
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33589542
[TBL] [Abstract][Full Text] [Related]
11. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
[TBL] [Abstract][Full Text] [Related]
12. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; ; Anlar B; Armangue T; Benseler S; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sartori S; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK
JAMA Neurol; 2021 Nov; 78(11):1333-1344. PubMed ID: 34542573
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis.
Guasp M; Módena Y; Armangue T; Dalmau J; Graus F
Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31900318
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of relapsing anti-N-methyl-D-aspartate receptor encephalitis].
Hongzhi G; Weize K; Bin P; Yan H; Qiang L; Yuan J; Qing L; Hang S; Haitao R; Yicheng Z; Dawei S; Liying C
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(13):996-1001. PubMed ID: 26506710
[TBL] [Abstract][Full Text] [Related]
15. Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.
Iizuka T; Kaneko J; Tominaga N; Someko H; Nakamura M; Ishima D; Kitamura E; Masuda R; Oguni E; Yanagisawa T; Kanazawa N; Dalmau J; Nishiyama K
JAMA Neurol; 2016 Jun; 73(6):706-13. PubMed ID: 27111481
[TBL] [Abstract][Full Text] [Related]
16. Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients.
Armangue T; Titulaer MJ; Málaga I; Bataller L; Gabilondo I; Graus F; Dalmau J;
J Pediatr; 2013 Apr; 162(4):850-856.e2. PubMed ID: 23164315
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis.
Morgan A; Li Y; Thompson NR; Milinovich A; Abbatemarco JR; Cohen JA; Ontaneda D; Punia V; Rae-Grant A; Galioto R; Kunchok A
Neurology; 2024 Feb; 102(4):e208019. PubMed ID: 38266213
[TBL] [Abstract][Full Text] [Related]
18. Treatment and outcome of children and adolescents with N-methyl-D-aspartate receptor encephalitis.
Zekeridou A; Karantoni E; Viaccoz A; Ducray F; Gitiaux C; Villega F; Deiva K; Rogemond V; Mathias E; Picard G; Tardieu M; Antoine JC; Delattre JY; Honnorat J
J Neurol; 2015 Aug; 262(8):1859-66. PubMed ID: 25987208
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of clinical characteristics and outcomes of mechanically ventilated patients with anti-N-methyl-D-aspartate receptor encephalitis].
Zhang Y; Su YY; Gao DQ; Ye H
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):187-192. PubMed ID: 28162168
[No Abstract] [Full Text] [Related]
20. Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis.
Kayser MS; Titulaer MJ; Gresa-Arribas N; Dalmau J
JAMA Neurol; 2013 Sep; 70(9):1133-9. PubMed ID: 23877059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]